Jubilant Ingrevia H1 Profit After Tax surged by 34%
Jubilant Ingrevia H1 Profit After Tax surged by 34% Markets Update: Across the broader Chemicals Industry, witnessing a steady recovery in volumes, even as pricing remains under pressure across all segments. At the same time, many global players, especially players in Europe are reporting deteriorating financials due to weaker demand, continued pricing pressure and elevated energy costs. The pharmaceutical end-use market continues to show steady volume growth, supported by stable pricing. Saw consistent volume expansion across CDMO and Fine-Chemicals products. Additionally, saw a marginal recovery in volumes last quarter within the Paracetamol segment. The global Agrochemical sector has successfully moved beyond the inventory destocking phase, with volumes now stabilizing and showing clear signs of growth. This upward momentum is supported by strong volume expansion on both YoY and QoQbasis. Pricing in the segment has remained stable over...